Blog
This Hot REIT Stock Still Has 20% Upside, According to 1 Wall Street Analyst
One real estate investment trust (REIT) stock is gaining attention on Wall Street. That may be because it has soared nearly 20% since the end of October. Yet one Wall Street analyst thinks Realty
Why Pfizer Stock Is Sinking Today
Shares of Pfizer (NYSE: PFE) were sinking 8.3% lower as of 11:25 a.m. ET on Wednesday. The sharp sell-off came after the drugmaker provided its guidance for full-year 2024.
Pfizer expects 2024
3 Hot Stocks That Can Double Again in 2024
Last month, I took a look at a few stocks that could double again in 2024. Let's try to unearth some more potential winners for next year.
DraftKings (NASDAQ: DKNG), CrowdStrike (NASDAQ: CRWD), and
Why Canopy Growth Stock Is Getting Smoked Today
Canopy Growth's (NASDAQ: CGC) share price is getting hit hard in Wednesday's trading. The marijuana stock was down 23.2% as of 10:45 a.m. ET, according to data from S&P Global Market Intelligence.
Want $500 in Annual Passive Income? Invest $11,000 in These 2 Dividend Stocks
Owning a diversified portfolio of high-quality dividend stocks is a great way for investors to minimize risk and build a reliable stream of passive income. But to build a high-performance dividend
The "Magnificent Seven" Stocks Crushed Wall Street in 2023, but This Stock Could Continue the Party in 2024
The "Magnificent Seven," a select group of the world's largest technology companies, has been the story of Wall Street this year. These stocks have seen gains of between 50% and 219% since in 2023.
IBM Has a Secret Weapon That's Bringing in Billions
Part of International Business Machines' (NYSE: IBM) strategy is to sell clients on its platforms. OpenShift, a container platform that enables running workloads across multiple clouds both public
Prepare for Higher Taxes in 2024 if Your Spouse Passed Away This Year
If you are a retiree who lost your spouse in 2023, I'm very sorry for your loss. Unfortunately, unless you're considered a qualifying widow or widower, your personal and emotional burden in 2023 may
Is Lumentum a Top Stock to Buy in 2024?
Lumentum's (NASDAQ: LITE) stock price has declined nearly 50% over the past three years. The maker of optical chips and lasers lost its luster as its revenue growth cooled off, its margins shrank
A Bull Market Is Coming: 1 Stock-Split Growth Stock to Buy Now With $50
In this video, I will be talking about an energy drink company called Celsius Holdings (NASDAQ: CELH). Celsius stock has been outperforming the market these past few years, had a 3-to-1 stock split
1 Biotech Stock That Could Be the Next Amgen
The human genome project, which was completed in 2003, marked a milestone for biotechnology. It opened the door for the creation of hundreds of medicines based on biology, which have improved the
1 Reason to Buy HubSpot Stock, and 1 Reason to Sell
Investors have been mainly focused on reasons to buy HubSpot (NYSE: HUBS) stock in 2023. That's because the software specialist is taking big steps toward profitability and has built a much larger
Why Microsoft Stock Could Run Out of Steam in 2024
Microsoft (NASDAQ: MSFT) is one of the "Magnificent Seven" -- a small set of massive tech companies that were key drivers of the S&P 500's impressive 20%-plus returns so far this year. The company's
Tesla Stock: Buy, Sell, or Hold for 2024 and Beyond?
Tesla (NASDAQ: TSLA) stock has served investors well in 2023. The electric-car maker's shares have soared more than 90% year to date. Indeed, the growth stock's performance has been so staggering
Ark Invest Bet $600 Million on This Tech Stock. Down 88%, Is It Time to Buy?
Professional money managers handle billions of dollars in client funds, putting immense pressure on them to perform. Cathie Wood's innovation-focused firm ARK Invest is no exception.
The company's
Pet Parents Keep Spending
In this podcast, Motley Fool analyst Bill Barker and host Deidre Woollard discuss:
Motley Fool host Mary Long talks with Dexcom CEO Kevin Sayer about the impact of weight loss drugs on diabetes
2 Big-Name Stocks Are Falling Wednesday -- Here's Why
The stock market looked ready to keep climbing early Wednesday, even as investors were largely in wait-and-see mode during the last day of the Federal Reserve's current monetary policy meeting
McDonald's Is Testing a Beverage Chain Concept. Why That Could Be Game-Changing for the Company.
McDonald's (NYSE: MCD) will soon test a concept for a small-format beverage concept called CosMc's. It has opened a test location in Bolingbrook, Illinois, soon followed by other test locations in
2 Dirt Cheap Stocks That Could Make You Richer in 2024
The past year has been a solid one for many investors, with the benchmark S&P 500 index up by an impressive 20% as many companies recovered from the economic uncertainty of the post-pandemic period.
Is Cisco Stock a Good Long-Term Investment?
Many tech stocks rebounded in 2023 from the prior year's steep downturn, and Silicon Valley veteran Cisco Systems (NASDAQ: CSCO) was among them. Shares reached a 52-week high of $58.19 on Sept. 1
Retail's Year in Review
Motley Fool host Deidre Woollard caught up with Motley Fool analyst Asit Sharma and contributor Toby Bordelon to check out the retail landscape.
They discuss:
To catch full episodes of all The
If You Had Invested $100 in AT&T in 1995, This Is How Much You Would Have Today
Telecommunications giant AT&T (NYSE: T) is a household name and a well-known dividend stock. Had you invested $100 in AT&T in 1995, your investment would have grown to $476 today. Is that good
3 Reasons to Buy British American Tobacco Stock Like There's No Tomorrow
The chief argument against owning any tobacco stock these days is undeniably solid: Smoking is on its way out. Although the prevalence of smokers has been dwindling for years, sheer population
This Artificial Intelligence (AI) Company Just Took a Page Out of Palantir's Playbook
Earlier this year, artificial intelligence (AI) and big data analytics company Palantir revealed a creative customer acquisition strategy. Namely, Palantir is hosting immersive bootcamps during
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
Outperforming the benchmark S&P 500 index over a long period is a formidable challenge. This task becomes even more daunting when choosing stocks from the healthcare sector, where the competitive


